The first short message went out over Arpanet, the precursor to the internet, 50 years ago this year—and it changed everything. Much of the change has been wonderful—as the internet has revolutionized communication, commerce, and access to information, in the process... Read more »
Later next month, the Midwest Growth Capital Symposium (MGCS) will kick off its 38th annual two-day event dedicated to showcasingthe region’s high-growth companies to a cadre of local and out-of-town investors.
During the symposium, 32 companies actively seeking funding... Read more »
Avidity Biosciences, a biotech developing drugs that deliver bits of RNA and DNA to cells to treat disease, has signed its first strategic pharmaceutical partner.
Eli Lilly (NYSE: LLY) is paying Avidity $20 million upfront—plus $15 million in equity—for the... Read more »
U.S. technology startups continue to pull in heaps of cash to try and stave off shortages of a crucial medical radioisotope.
NorthStar Medical Technologies said this week it closed a deal to receive up to $100 million in secured debt financing... Read more »
Forge Therapeutics, founded in 2015 with the goal of developing drugs that target metalloenzymes, said Wednesday it had agreed to let Basilea Pharmaceutica use its chemistry platform to develop new antibiotics.
Basilea, a Swiss company, has previously commercialized two drugs, an... Read more »
San Antonio—Rackspace said Wednesday it has hired Kevin Jones, who most recently ran Dallas-based bus and transportation contracting business MV Transportaiton, as its CEO. Jones replaces Joe Eazor, who had held the top job at Rackspace since mid-2017.
Apollo Global... Read more »
Digital Guardian is taking in a chunk of capital and adding a slate of new executives to push its cybersecurity software, amid businesses’ renewed concerns over digital attacks and need to comply with the latest privacy and data protection mandates.
The... Read more »
[Updated, 1:00 pm ET, see below.] A month after the failure of its once-promising Alzheimer’s disease drug aducanumab shattered its share price, Biogen is trying to pick up the pieces.
Biogen (NASDAQ: BIIB) hosted a conference call Wednesday... Read more »
Can an artistic genius and a whip-smart computer get along?
French designer Philippe Starck—whose work is a mainstay of museum exhibitions—decided to find out. About two years ago, Starck heard that 3D engineering software company Autodesk (NASDAQ: ADSK) was using... Read more »
With a second big clinical failure, Teva Pharmaceutical is abandoning efforts to extend the use of its approved migraine drug to the treatment of cluster headaches, a rarer form of headache that typically affects one side of the head... Read more »
CI Security, a startup that provides its customers with cybersecurity software and expertise in detecting and responding to digital intrusions and threats, announced Monday it has raised $9.6 million in new funding. Seattle-based CI Security, which was previously known as... Read more »
[Corrected 4/23/19, 4:17 pm CT. See below.] Imbed Biosciences, a developer of ultra-thin, silver-based wound dressing materials, will step up its sales and marketing efforts with the help of a fresh $2 million venture investment.
The Series A round... Read more »
Censinet, a Boston startup helping hospitals and other healthcare providers manage the cyber risk of their hundreds of third-party vendors, has launched its system and announced $7.8 million in funding to double its headcount in a year, further develop its platform,... Read more »